Seffalair Spiromax 유럽 연합 - 덴마크어 - EMA (European Medicines Agency)

seffalair spiromax

teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - medicin for obstruktiv sygdomme, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

Seretide 25+250 mikrogram inhalationsspray, suspension 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

seretide 25+250 mikrogram inhalationsspray, suspension

paranova danmark a/s - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+250 mikrogram

Seretide 25+125 mikrog./dosis inhalationsspray, suspension 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

seretide 25+125 mikrog./dosis inhalationsspray, suspension

orifarm a/s - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+125 mikrog./dosis

Seretide 25+125 mikrog./dosis inhalationsspray, suspension 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

seretide 25+125 mikrog./dosis inhalationsspray, suspension

chemvet pharma aps - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+125 mikrog./dosis

Seretide 25+250 mikrog./dosis inhalationsspray, suspension 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

seretide 25+250 mikrog./dosis inhalationsspray, suspension

glaxosmithkline pharma a/s - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+250 mikrog./dosis

Seretide 25+250 mikrog./dosis inhalationsspray, suspension 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

seretide 25+250 mikrog./dosis inhalationsspray, suspension

abacus medicine a/s - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+250 mikrog./dosis